Johnson Financial Group Inc (Wisconsin)’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.56K Hold
119
– – ﹤0.01% 701
2026
Q1
$2.53K Hold
119
– – ﹤0.01% 759
2025
Q4
$1.94K Hold
119
– – ﹤0.01% 821
2025
Q3
$1.39K Buy
+119
New +$1.55K ﹤0.01% 976

Other funds holding TXG

Johnson Financial Group Inc (Wisconsin)'s TXG Position: Q2 2026 in Review

Johnson Financial Group Inc (Wisconsin) held its 10x Genomics (TXG) position steady in Q2 2026 at 119 shares worth $4.56K. The position accounts for ﹤0.01% of the portfolio, ranked #701.

Johnson Financial Group Inc (Wisconsin) first reported a position in TXG in Q3 2025 and has held it in 4 quarters since. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Johnson Financial Group Inc (Wisconsin) held 119 shares of 10x Genomics worth $4.56K as of Q2 2026.
  • Johnson Financial Group Inc (Wisconsin) left its 10x Genomics share count unchanged in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q2 2026, its #701 holding.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in 10x Genomics in Q3 2025 and has held it in 4 quarters since.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.